Evidence map›Paper›PMID 23955773›Full record

ArticleNature methods2013

Recombinant antibodies to histone post-translational modifications.

Takamitsu Hattori, Joseph M Taft, Kalina M Swist, Hao Luo, Heather Witt, Matthew Slattery, Akiko Koide, Alexander J Ruthenburg, Krzysztof Krajewski, Brian D Strahl and 4 more

Abstract read
In one paragraph

Article in Nature methods, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Binding mode-guided development of high-performance antibodies targeting site-specific posttranslational modifications.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Engineering Binders with Exceptional Selectivity.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Next-generation antibodies for post-translational modifications.Current opinion in structural biology · 2018
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Detection of Isoforms Differing by a Single Charge Unit in Individual Cells.Angewandte Chemie (International ed. in English) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Takamitsu HattoriDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois, USA.
Joseph M Taft
Kalina M Swist
Hao Luo
Heather Witt
Matthew Slattery
Akiko Koide
Alexander J Ruthenburg
Krzysztof Krajewski
Brian D Strahl
Kevin P White
Peggy J Farnham
Yingming Zhao
Shohei Koide

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
A Cis Regulatory map of the Drosophila GenomeU01HG004264 · NHGRI · UNIVERSITY OF CHICAGO · PI WHITE, KEVIN P. · 2007 to 2011
$12.1M
Integrated Epigenetic Maps of Human Embryonic and Adult CellsU01ES017154 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COSTELLO, JOSEPH F, MARRA, MARCO ANTONIO · 2008 to 2012
$11.6M
A high-throughput approach towards deciphering the histone codeR01GM085394 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STRAHL, BRIAN D · 2008 to 2011
$1.2M
Renewable synthetic antibodies for epigenomicsRC1DA028779 · NIDA · UNIVERSITY OF CHICAGO · PI KOIDE, SHOHEI · 2009 to 2010
$1.0M
Novel affinity reagents for epigenetics markersR21DA025725 · NIDA · UNIVERSITY OF CHICAGO · PI KOIDE, SHOHEI · 2008 to 2009
$604k
NCI NIH HHS P30 CA016086NHGRI NIH HHS U01 HG004264NIDA NIH HHS R21 DA025725NIDA NIH HHS RC1 DA028779NIEHS NIH HHS U01 ES017154NIGMS NIH HHS GM085394NIGMS NIH HHS R01 GM085394
6 · The paper itself

Abstract

Variability in the quality of antibodies to histone post-translational modifications (PTMs) is a widely recognized hindrance in epigenetics research. Here, we produced recombinant antibodies to the trimethylated lysine residues of histone H3 with high specificity and affinity and no lot-to-lot variation. These recombinant antibodies performed well in common epigenetics applications, and enabled us to identify positive and negative correlations among histone PTMs.

Indexed as

Antibody AffinityProtein Processing, Post-TranslationalAnimalsAntibodiesBinding Sites, AntibodyCell LineEscherichia coliHistonesHumansLysinePeptide LibrarySensitivity and SpecificitySingle-Chain AntibodiesAntibodiesHistonesLysinePeptide LibrarySingle-Chain Antibodies

Identifiers

PMID23955773
PMCPMC3828030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.